Blog — Obesity Medicine Explained
Plain-language, sourced articles on obesity medicines, metabolic health and longevity. General information, not medical advice.
- The 310-fold number: GLP-1 prescribing in children under 12
- Beyond GLP-1: why drugmakers are suddenly racing over muscle
- GLP-1 and PMOS: what the early studies show, and why insurers still say no
- Who pays for weight-loss drugs? The coverage map is splitting in two
- Beyond Weight Loss: What the Latest GLP-1 Results Mean for Patients
- Why Novo Nordisk and Eli Lilly Are Suing Each Other - and What It Means for You
- Wegovy Pill vs Foundayo: Which Oral GLP-1 Might Fit You?
- GLP-1 and Your Heart: More Than Weight Loss
- Weight-Loss Pills Are Here: How Oral GLP-1s Compare to Injections
- Medicare Now Helps Pay for Obesity Drugs: The New 50 Dollar GLP-1 Bridge
- Do Weight-Loss Drugs Like Wegovy Steal Your Muscle?